Search | IOVS | ARVO Journals

Showing 1 – 17 of 17

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Insights into cardiovascular disorders (CVD) risk in patients with paracentral acute middle maculopathy (PAMM)

Celeste Limoli; Laxmi Raja; Siegfried Wagner; Stela Vujosevic; Paolo Nucci; Hagar Khalid; Pearse Andrew Keane; Josef Christian Huemer

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1733.

ARVO Annual Meeting Abstract June 2024

Demographic and Phenotypic Analysis of Acute Macular Neuroretinopathy: Insights from a Large Single-Center Retrospective Cohort Study

Hagar Khalid; Celeste Limoli; Laxmi Raja; Siegfried Wagner; Stela Vujosevic; Paolo Nucci; Josef Christian Huemer; Pearse Andrew Keane

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5505.

ARVO Annual Meeting Abstract June 2024

Retinal morphological differences in atypical Parkinsonism: A cross-sectional analysis of the AlzEye cohort

Laxmi Raja; Salil Patel; Dominic Williamson; Robbert Struyven; Yukun Zhou; Alastair Denniston; Axel Petzold; Chrystalina Antoniades; Siegfried Wagner; Pearse Andrew Keane

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6675.

ARVO Annual Meeting Abstract June 2023

Associations of Retinal Vascular Morphology and Inflammatory Bowel Disease: A cross-sectional analysis.

Laxmi Raja; Timing Liu; Yukun Zhou; Robbert Struyven; Dominic Williamson; Mario Cortina Borja; David Romero-Bascones; Anthony P Khawaja; Praveen J Patel; Daniel Alexander; Konstantinos Balaskas; Jugnoo Rahi; Alastair K Denniston; Axel Petzold; Siegfried Wagner; Pearse Keane

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3734.

ARVO Annual Meeting Abstract June 2023

Paracentral acute middle maculopathy(PAMM): clinical characteristics, risk factors, and prognostic outcomes

Celeste Limoli; Laxmi Raja; Siegfried Wagner; Hagar Khalid; Stela Vujosevic; Paolo Nucci; Pearse Keane; Josef Christian Huemer

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3664.

ARVO Annual Meeting Abstract June 2022

Exploring barriers and solutions to digital inclusion in outpatient Ophthalmology

Claus Christian Gruber; Rishi Ramessur; Laxmi Raja; Magdalene YL Ting; Benjamin Riley; Dawn Sim; Swan Kang

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1419 – A0115.

ARVO Annual Meeting Abstract June 2022

Outpatient workshops to improve digital health literacy: lessons learned

Rishi Ramessur; Claus Christian Gruber; Hardeep Kandola; Amrit Kaur Sehmi; Laxmi Raja; Sarah Thomas; Dawn Sim; Swan Kang

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1417 – A0113.

ARVO Annual Meeting Abstract June 2022

Determinants of non-attendance in synchronous teleophthalmology clinics.

Laxmi Raja; Siegfried Wagner; Robbert Struyven; Mario Cortina-Borja; Pearse Andrew Keane; Josef Huemer; Konstantinos Balaskas; Dawn Sim; Jugnoo Rahi; Ameenat Lola Solebo; Swan Kang

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1412 – A0108.

ARVO Annual Meeting Abstract June 2022

Telepresence robots in medical education and eye health care delivery

Mustafa Al-Asady; Hussein Peeth; Amit Gupta; Laxmi Raja; Claire Lovegrove; Peter Thomas; Dawn Sim; Swan Kang

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1084 – A0179.

ARVO Annual Meeting Abstract June 2022

Incident cardiovascular events following paracentral acute middle maculopathy

Hagar Khalid; Siegfried Wagner; Laxmi Raja; Josef Huemer; Daniel Ferraz; Konstantinos Balaskas; Dawn Sim; Pearse Andrew Keane

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1750 – F0210.

ARVO Annual Meeting Abstract June 2022

Determinants of Non-Attendance in Face-to-Face Ophthalmic Clinics Pre- and During the Coronavirus Pandemic

Amit Gupta; Siegfried Wagner; Laxmi Raja; Robbert Struyven; Mario Cortina-Borja; Pearse Andrew Keane; Josef Huemer; Konstantinos Balaskas; Dawn Sim; Jugnoo Rahi; Ameenat Solebo; Swan Kang

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2813 – A0143.

ARVO Annual Meeting Abstract June 2022

Determinants of non-attendance in asynchronous telemedicine ophthalmology clinics

Ciara O'Byrne; Siegfried Wagner; Laxmi Raja; Robbert Struyven; Mario Cortina-Borja; Pearse Andrew Keane; Josef Huemer; Konstantinos Balaskas; Dawn Sim; Jugnoo Rahi; Ameenat Lola Solebo; Swan Kang

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3825.

ARVO Annual Meeting Abstract June 2021

Investigating the impact of saliency maps on clinician’s confidence in model predictions

Sara Beqiri; Abdallah Abbas; Edward Korot; Siegfried Wagner; Robbert Struyven; Madeline Kelly; Ritvij Singh; Daniel Ferraz; Mariana Batista Goncalves; Josef Christian Huemer; Hagar Khalid; Laxmi Raja; Pearse A Keane

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2297.

ARVO Annual Meeting Abstract June 2020

Choroidal neovascularization mimics in chronic central serous chorioretinopathy; an optical coherence tomography angiography study.

Laxmi Raja; Hagar Khalid; Josef Christian Huemer; Shruti Chandra; Luke Nicholson; Siegfried Wagner; Daniel Ferraz; Ahmed M Hagag; Dawn A Sim; Konstantinos Balaskas; Sobha Sivaprasad; Gongyu Zhang; Pearse Andrew Keane

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4811.

ARVO Annual Meeting Abstract July 2018

One and two-year visual acuity outcomes after treatment for neovascular age-related macular degeneration at a large tertiary ophthalmic hospital

Katrin Fasler; Farid Afshar; Reena Chopra; Karsten Ulrich Kortuem; Nikolas Pontikos; Siegfried K Wagner; Laxmi Raja; Hasaneen Al Janabi; Thushanthi Ramakrishnan; GABRIELLA CLAIRE PRESTON; Konstantinos Balaskas; Adnan Tufail; Praveen Patel; Pearse Keane

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):826.

ARVO Annual Meeting Abstract July 2018

Visual outcomes after 50 or more intravitreal anti-VEGF injections for neovascular age-related macular degeneration at a large tertiary ophthalmic hospital

Karsten Ulrich Kortuem; Thushanthi Ramakrishnan; Katrin Fasler; Reena Chopra; NIKOLAS PONTIKOS; Siegfried Wagner; Laxmi Raja; Hasaneen Al Janabi; Farid Afshar; Ella Preston; Praveen Patel; Adnan Tufail; Konstantinos Balaskas; Pearse Keane

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):838.

ARVO Annual Meeting Abstract July 2018

Five-year visual acuity outcomes after treatment for neovascular age-related macular degeneration at a large tertiary ophthalmic hospital

Thushanthi Ramakrishnan; Katrin Fasler; Reena Chopra; Karsten Ulrich Kortuem; Nikolas Pontikos; Siegfried K Wagner; Laxmi Raja; Hasaneen Al Janabi; Farid Afshar; GABRIELLA CLAIRE PRESTON; Konstantinos Balaskas; Praveen Patel; Adnan Tufail; Pearse Keane

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1471.

NARROW

Content Type

Journal

Article Type

Specify Date Range

Insights into cardiovascular disorders (CVD) risk in patients with paracentral acute middle maculopathy (PAMM)

Demographic and Phenotypic Analysis of Acute Macular Neuroretinopathy: Insights from a Large Single-Center Retrospective Cohort Study

Retinal morphological differences in atypical Parkinsonism: A cross-sectional analysis of the AlzEye cohort

Associations of Retinal Vascular Morphology and Inflammatory Bowel Disease: A cross-sectional analysis.

Paracentral acute middle maculopathy(PAMM): clinical characteristics, risk factors, and prognostic outcomes

Exploring barriers and solutions to digital inclusion in outpatient Ophthalmology

Outpatient workshops to improve digital health literacy: lessons learned

Determinants of non-attendance in synchronous teleophthalmology clinics.

Telepresence robots in medical education and eye health care delivery

Incident cardiovascular events following paracentral acute middle maculopathy

Determinants of Non-Attendance in Face-to-Face Ophthalmic Clinics Pre- and During the Coronavirus Pandemic

Determinants of non-attendance in asynchronous telemedicine ophthalmology clinics

Investigating the impact of saliency maps on clinician’s confidence in model predictions

Choroidal neovascularization mimics in chronic central serous chorioretinopathy; an optical coherence tomography angiography study.

One and two-year visual acuity outcomes after treatment for neovascular age-related macular degeneration at a large tertiary ophthalmic hospital

Visual outcomes after 50 or more intravitreal anti-VEGF injections for neovascular age-related macular degeneration at a large tertiary ophthalmic hospital

Five-year visual acuity outcomes after treatment for neovascular age-related macular degeneration at a large tertiary ophthalmic hospital

To View More...

You must be signed into an individual account to use this feature.